Approval · Notice of Compliance 32914 · 2024
APOQUEL: Notice of Compliance 32914
Issued March 20, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32914
- Date
- March 20, 2024
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug substance supplier
Products in this notice
Medicinal ingredients
- OCLACITINIB MALEATE 3.6 MG per TAB
- OCLACITINIB MALEATE 5.4 MG per TAB
- OCLACITINIB MALEATE 16 MG per TAB